Description of CARDACUDARINE (GW-501516) Capsules:
CARDACUDARINE (GW-501516) Capsules have demonstrated significant effectiveness in treating Class I, II, and III obesity, without negatively impacting the cardiorespiratory system. Clinical trials have also shown its potential in the preventive treatment of diabetes.
Composition of CARDACUDARINE (GW-501516) Capsules:
Each bottle contains 60 capsules, with each capsule containing 10mg of Cardarine (GW-501516).
Contraindications of CARDACUDARINE (GW-501516) Capsules:
CARDACUDARINE (GW-501516) Capsules are contraindicated in women who are pregnant or may become pregnant, as they can cause fetal harm. If pregnancy occurs during treatment, the patient should be made aware of the potential risks to the fetus.
Precautions for CARDACUDARINE (GW-501516) Capsules:
CARDACUDARINE (GW-501516) Capsules may cause suppression of clotting factors II, V, VII, and X, leading to an increased prothrombin time. Patients on high doses should have their hemoglobin and hematocrit levels regularly monitored to check for polycythemia.
Side Effects of CARDACUDARINE (GW-501516) Capsules:
Prolonged use of CARDACUDARINE (GW-501516) Capsules for over 40 weeks has been reported to increase the growth of cancer cells in the liver, bladder, stomach, skin, thyroid, tongue, testes, ovaries, and womb.
Storage:
Store CARDACUDARINE (GW-501516) Capsules at room temperature, away from heat and direct sunlight, to maintain their effectiveness and stability.
DISCLAIMER: The content on this website, including text, images, and audio, is for informational purposes only and should not replace professional medical advice or treatment. We do not recommend specific medications or offer medical consultations. When considering the use of CARDACUDARINE (GW-501516) Capsules by Denik Pharma, it’s important to weigh the potential side effects and health risks. Consultation with a healthcare provider or sports medicine specialist is strongly recommended before use.
